Join Us at ACC.26
Heartflow is excited to take part in the American College of Cardiology (ACC) Annual Scientific Meeting on March 28–30 in New Orleans, Louisiana.
Hear and learn more about Heartflow on the podium, in abstracts, during our innovation session, and at our booth. Through hands-on demonstrations and conversations with our team at the booth, we will showcase Heartflow Plaque Analysis as a clinically validated tool to predict risk based on Total Plaque Volume (TPV). Join us at the booth for an informal, HCP-led single-topic 10–15 minute "snack-n-learn" session.
Heartflow is also proud to sponsor CCTA scans with the Heartflow Plaque and FFRCT Analysis (as medically necessary) during ACC. See below for more information.
How to Connect with Us
Private Meeting with Heartflow Leadership
Request a meeting with our Executive Leadership Team. Your local representative will contact you.
Educational Dinner
The Precision Imperative: Integrating AI-Plaque Analysis to Personalize Cardiovascular Risk and Management
Location: Generations Hall
310 Higgins Blvd, New Orleans
(1.5 blocks from the Convention Center)
Join us to explore the shift in cardiovascular care. As new evidence and reimbursement converge, we’ll discuss how Heartflow Plaque Analysis provides the insights needed for more precise risk assessment and management. Learn to identify the right patients for earlier, personalized, and proactive intervention
Moderator:
Nihar Desai, MD
New Haven, CT
Speakers:
Sarah Rinehart, MD
Charleston, WV
Ron Blankstein, MD
Brigham and Women’s Hospital
Boston, MA
Innovation Session
Reframing Cardiovascular Risk Assessment: The Role of CCTA and Plaque Analysis
Moderator:
Nihar Desai, MD
New Haven,
Ron Blankstein, MD
Brigham and Women’s Hospital
Boston, MA
These events are not part of ACC.26, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
Abstract Poster Sessions
Sunday, March 29, 2026
Location: Hall E
10:06-10:13 AM
AI- Based Coronary Plaque Analysis and Adverse Cardiovascular Events: the Mass General Brigham CCTA Registry
12:30-1:30 PM
Comparative Effectiveness of Coronary Computed Tomographic Angiography with or without AI-Plaque Analysis and Stress Testing on Lipid Lowering After One Year: A Primary Analysis of the DECIDE (AI-Derived Plaque Quantification: CTA and AI-Q CPA for Determining Effective CADManagement) Registry
12:30-1:30 PM
Budget Impact Analysis of Artificial Intelligence-Guided Coronary Plaque Analysis vs. Usual Care from a US Payer Perspective
Snack-n-Learn Sessions at Booth #1919
Snack and Learn:
PCI Navigator
Saturday, March 28 | 1–1:10 PM & 3–3:10 PM
PCI Navigator: Confidence to Plan Interventions with Precision X2. Discover how to plan CT-guided PCI with PCI Navigator— turning 3D anatomy, plaque insights, and physiology into confident interventions.
Evan Shlofmitz , DO
St. Francis Hospital
Roslyn, NY
Snack and Learn:
Heartflow Plaque Analysis
Sunday, March 29 | 10:30–10:40 AM
Heartflow Plaque Analysis in Action: Follow one real-world patient with CAD from the CCTA to how Heartflow Plaque Analysis adds clarity, staging, and clinical value—backed by DECIDE Registry evidence.
Sarah Rinehart, MD
Charleston Area
Medical Center
Charleston, WV
Snack and Learn:
Plaque, Risk, Action
Sunday, March 29 | 3:00–3:10 PM
Plaque, Risk, Action: What the Latest Consensus Statements Means for Practice. See why plaque matters for prevention, how consensus is redefining risk in nonobstructive CAD, and how the recent ACC consensus provides a practical roadmap for applying plaque analysis in clinical care.
Jonathon Leipsic, MD
Past President, SCCT Vancouver, BC, Canada
DECIDE Demo
Saturday, March 28–Monday, March 30
Participate in an interactive demonstration of the Heartflow Plaque Analysis platform featured in the DECIDE Registry. Gain firsthand insights into how advanced coronary plaque assessment enhances clinical decision-making. Visit the Heartflow booth to explore the technology in action and discover its role in improving cardiovascular risk stratification and optimizing patient management.
These events are not part of ACC.26, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
Do You Know Your Risk of Heart Disease?
As the exclusive sponsor of ACC’s onsite CCTA screening initiative, attendees are invited to receive a complimentary Coronary Computed Tomography Angiography (CCTA) scan enhanced by Heartflow’s non-invasive Plaque and FFRct Analysis (as medically necessary). See firsthand how CCTA and AI-enhanced tools improve diagnostic accuracy and guide treatment plans.
The experience includes an on-site scan and a dedicated consultation with a cardiologist to discuss your eligibility and review results.
Registration and prescreening are required. Slots are limited.
The Heartflow Analysis is indicated for use in adult patients with suspected coronary artery disease. Participation is subject to a medical necessity determination by a qualified physician at the event; therefore, not all interested parties may qualify. For complete indications for use and safety details, refer to: heartflow.com/indications.
